Indivior Pharmaceuticals, Inc.
INDVIndivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 30, 2026
10dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
INDV Earnings Report
EPS Est: $0.97 | FQ end 2026-06
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Indivior Pharmaceuticals, Inc.'s next FDA catalyst?→
Indivior Pharmaceuticals, Inc.'s (INDV) next tracked catalyst is a Earnings expected July 30, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track INDV biotech catalysts?→
Add INDV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Indivior Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.